Empathy, affection, and sociability enhancement

Empathy, affection, and sociability enhancement is the experience of a mind state that is dominated by intense feelings of compassion, talkativeness, and happiness.^[1]^[2]^[3] The experience of this effect creates a wide range of subjective changes to a person's perception of their feelings towards other people and themselves. These are described and documented in the list below:

Increased sociability and the feeling that communication comes easier and more naturally.
Increased urge to communicate or express one's affectionate feelings towards others, even if they happen to be strangers.
Increased feelings of empathy, love, and connection with others.
Increased motivation to resolve social conflicts and improve interpersonal relationships.
Decreased negative emotions and mental states such as stress, anxiety, and fear.
Decreased insecurity, defensiveness, and fear of emotional injury or rejection from others.
Decreased irritability, aggression, anger, and jealousy.

Empathy, affection, and sociability enhancement is often accompanied by other coinciding effects, such as stimulation, personal bias suppression, motivation enhancement, and anxiety suppression. It is most commonly induced under the influence of moderate dosages of entactogenic compounds, such as MDMA^[4]^[5], 4-FA^[6]^[7], and 2C-B^[8]^[9]. However, it can also subtly occur to a much lesser extent under the influence of GABAergic depressants and certain stimulants.^[10]

This effect seems to be mentioned within the following trip reports:

I designed it this way myself

on December 29, 2013 - Oscarette

MDMA 150mg Oral
2C-B 20mg Oral

I Am a Big Gushing Fool

on 04/2016 - nervewing

5-APDB 100 mg Oral in gel cap

Wisdom Through Pain

on 06/2016 - nervewing

2C-T-7 25 mg Oral via gel cap

Resplendent and Warm

on 07/2015 - nervewing

4-AcO-MET 40 mg Oral in solution

Opening Up

on 03/2017 - nervewing

6-APB 115 mg + 25 mg Oral in gel cap

References

Nichols, D. E. (1986). Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens. Journal of psychoactive drugs, 18(4), 305-313. | https://doi.org/10.1080/02791072.1986.10472362
The Great Entactogen - Empathogen Debate (from the Newsletter of the Multidisciplinary Association for Psychedelic Studies, MAPS - Volume 4 Number 2 Summer 1993 - pp 47-49 | https://www.maps.org/news-letters/v04n2/04247eed.html
Bedi, G., Hyman, D., & de Wit, H. (2010). Is ecstasy an “empathogen”? Effects of±3, 4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others. Biological psychiatry, 68(12), 1134-1140. | https://dx.doi.org/10.1016%2Fj.biopsych.2010.08.003
Scahill, L., & Anderson, G. M. (2010). Is ecstasy an empathogen?. Biological psychiatry, 68(12), 1082. | https://dx.doi.org/10.1016%2Fj.biopsych.2010.10.020
MDMA effects (Erowid) | https://erowid.org/chemicals/mdma/mdma_effects.shtml
4-FA (The Drug Classroom) | https://thedrugclassroom.com/video/4-fluoroamphetamine-4-fa/
4-Fluoroamphetamine(4-FA) – Critical Review Report | http://www.who.int/medicines/access/controlled-substances/5.4_4-FA_CRev.pdf?ua=1
2C-B effects (Erowid) | https://erowid.org/chemicals/2cb/2cb_effects.shtml
González, D., Torrens, M., & Farré, M. (2015). Acute effects of the novel psychoactive drug 2C-B on emotions. BioMed research international, 2015. | https://dx.doi.org/10.1155%2F2015%2F643878
Wardle, M. C., Garner, M. J., Munafò, M. R., & de Wit, H. (2012). Amphetamine as a social drug: effects of d-amphetamine on social processing and behavior. Psychopharmacology, 223(2), 199-210. | https://dx.doi.org/10.1007%2Fs00213-012-2708-y